Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$47.98 - $54.4 $80,078 - $90,793
-1,669 Reduced 3.08%
52,578 $2.85 Million
Q4 2023

Jan 19, 2024

SELL
$48.48 - $57.85 $141,513 - $168,864
-2,919 Reduced 5.11%
54,247 $2.78 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $137,720 - $153,992
2,379 Added 4.34%
57,166 $3.32 Million
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $3.49 Million - $3.88 Million
54,787 New
54,787 $3.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Synergy Asset Management, LLC Portfolio

Follow Synergy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synergy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Synergy Asset Management, LLC with notifications on news.